Genetic Analysis AS (NGM: GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK0.518
-0.072 (-12.20%)
At close: Nov 20, 2024
Genetic Analysis AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 11.4 | 16.29 | 25.32 | 46.81 | 24.19 | 4.01 | Upgrade
|
| Cash & Short-Term Investments | 11.4 | 16.29 | 25.32 | 46.81 | 24.19 | 4.01 | Upgrade
|
| Cash Growth | 16.73% | -35.67% | -45.90% | 93.48% | 502.76% | -80.18% | Upgrade
|
| Accounts Receivable | 1.46 | 1.9 | 2.61 | 1.05 | 0.86 | 7.22 | Upgrade
|
| Other Receivables | 6.85 | 9.15 | 4.99 | 6.95 | 0.73 | 4.77 | Upgrade
|
| Receivables | 8.31 | 11.04 | 7.6 | 8 | 1.59 | 11.98 | Upgrade
|
| Inventory | 1.46 | 1.54 | 1.75 | 2.37 | 1.89 | 0.76 | Upgrade
|
| Prepaid Expenses | - | 0.18 | 0.76 | 0.42 | 0.34 | 0.18 | Upgrade
|
| Total Current Assets | 21.17 | 29.06 | 35.44 | 57.6 | 28.01 | 16.94 | Upgrade
|
| Property, Plant & Equipment | 5.01 | 6.19 | 8.14 | 1.59 | 1.62 | 3.13 | Upgrade
|
| Long-Term Investments | -0.03 | 0.41 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 15.47 | 0.58 | 0.15 | 0.16 | 0.17 | 0.52 | Upgrade
|
| Long-Term Deferred Charges | - | 17.25 | 20.7 | 24.15 | 25.82 | 24.99 | Upgrade
|
| Other Long-Term Assets | -0 | 0 | - | -0 | - | - | Upgrade
|
| Total Assets | 41.62 | 53.49 | 64.42 | 83.49 | 55.62 | 45.59 | Upgrade
|
| Accounts Payable | 3.74 | 5.58 | 4.62 | 2.41 | 1.74 | 0.89 | Upgrade
|
| Accrued Expenses | - | 8.49 | 6.55 | 6.05 | 4.35 | 5.09 | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.4 | 0.4 | 0.4 | 0.4 | 0.1 | Upgrade
|
| Current Portion of Leases | - | 1.57 | 1.38 | 1.1 | 1.06 | 1.19 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.05 | 1.99 | Upgrade
|
| Other Current Liabilities | 5.63 | - | -0 | - | - | - | Upgrade
|
| Total Current Liabilities | 9.37 | 16.04 | 12.95 | 9.97 | 7.59 | 9.26 | Upgrade
|
| Long-Term Debt | 4.8 | 0.3 | 0.7 | 1.1 | 1.1 | 1.5 | Upgrade
|
| Long-Term Leases | 4.02 | 5.15 | 6.64 | 0.33 | 0.3 | 1.3 | Upgrade
|
| Other Long-Term Liabilities | 0 | -0 | 0 | - | - | 0 | Upgrade
|
| Total Liabilities | 18.19 | 21.49 | 20.28 | 11.4 | 9 | 12.06 | Upgrade
|
| Common Stock | 29.63 | 22.92 | 14.95 | 14.95 | 10.3 | 6.87 | Upgrade
|
| Additional Paid-In Capital | 7.64 | 5.95 | 29.19 | 57.14 | 36.32 | 147.75 | Upgrade
|
| Retained Earnings | -13.84 | - | - | - | - | -121.09 | Upgrade
|
| Comprehensive Income & Other | - | 3.13 | - | 0 | - | - | Upgrade
|
| Shareholders' Equity | 23.43 | 32 | 44.14 | 72.09 | 46.62 | 33.53 | Upgrade
|
| Total Liabilities & Equity | 41.62 | 53.49 | 64.42 | 83.49 | 55.62 | 45.59 | Upgrade
|
| Total Debt | 8.82 | 7.42 | 9.12 | 2.93 | 2.86 | 4.09 | Upgrade
|
| Net Cash (Debt) | 2.58 | 8.87 | 16.2 | 43.88 | 21.33 | -0.07 | Upgrade
|
| Net Cash Growth | -32.99% | -45.23% | -63.07% | 105.71% | - | - | Upgrade
|
| Net Cash Per Share | 0.05 | 0.23 | 0.65 | 1.75 | 1.24 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 49.38 | 38.2 | 24.92 | 24.92 | 17.17 | 11.45 | Upgrade
|
| Total Common Shares Outstanding | 49.38 | 38.2 | 24.92 | 24.92 | 17.17 | 11.45 | Upgrade
|
| Working Capital | 11.8 | 13.01 | 22.49 | 47.63 | 20.42 | 7.68 | Upgrade
|
| Book Value Per Share | 0.47 | 0.84 | 1.77 | 2.89 | 2.72 | 2.93 | Upgrade
|
| Tangible Book Value | 7.95 | 31.41 | 43.99 | 71.93 | 46.45 | 33.01 | Upgrade
|
| Tangible Book Value Per Share | 0.16 | 0.82 | 1.77 | 2.89 | 2.71 | 2.88 | Upgrade
|
| Machinery | - | 3.33 | 3.21 | 3.25 | 3.17 | 3.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.